We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Survival Rates Improve for Infant Heart Surgery

By HospiMedica staff writers
Posted on 27 Nov 2000
A study has found that survival rates have been steadily improving for infants who undergo surgery for hypoplastic left heart syndrome (HLHS), a life-threatening congenital condition. More...
The study reported on 840 infants operated on for HLHS at the Children's Hospital of Philadelphia (PA, USA) and was published in a November supplement of Circulation.

HLHS is the second-most common congenital heart defect presenting in the first week of life, and without surgery is invariably fatal. Currently, surgery is performed in three stages: the first on newborns, the second at about six months of age, and a third--the Fontan procedure--between one and two years of age. Researchers found that rates for hospital survival after the first stage improved from 56% in 1984-1989 to 71% in 1995-1998. Even better, survival rates for January 1999 through April 2000 showed an 86% survival rate.

The improved survival rates are the result of refinements in surgical techniques and in the pre-and post-surgical management of children with HLHS. Two other contributing factors were the introduction of the intermediate surgical procedure in 1989 and the increased experience of surgeons.

"Until now, relatively litle has been known about longer-term survival of patients with HlHS, but our study shows very few late deaths among patients discharged after the third stage,” said William Mahle, M.D., attending cardiologist at the Cardiac Center of The Children's Hospital.



Related Links:
Children's Hospital of Philadelphia

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.